Posted by Admin 1 year ago


The trial has commenced.  

Read more

Sudha Rao

On the 1 February this year the ACT Government approved the establishment of Epi Axis Therapeutics. Epi Axis was established to commercialise the innovative therapy developed by University of Canberra Professor in Molecular and Cellular Biology Dr Sudha Rao that aims to prevent breast cancer metastasis. Dr Rao and her team were the first to…

Read more